The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies

Jennifer El Diaz, Mehmet Eren Ahsen, Thomas Schaffter, Xintong Chen, Ronald B Realubit, Charles Karan, Andrea Califano, Bojan Losic, Gustavo Stolovitzky

Research output: Contribution to journalArticlepeer-review

Abstract

Our ability to discover effective drug combinations is limited, in part by insufficient understanding of how the transcriptional response of two monotherapies results in that of their combination. We analyzed matched time course RNAseq profiling of cells treated with single drugs and their combinations and found that the transcriptional signature of the synergistic combination was unique relative to that of either constituent monotherapy. The sequential activation of transcription factors in time in the gene regulatory network was implicated. The nature of this transcriptional cascade suggests that drug synergy may ensue when the transcriptional responses elicited by two unrelated individual drugs are correlated. We used these results as the basis of a simple prediction algorithm attaining an AUROC of 0.77 in the prediction of synergistic drug combinations in an independent dataset.

Original languageEnglish (US)
JournaleLife
Volume9
DOIs
StateAccepted/In press - Sep 18 2020
Externally publishedYes

Fingerprint Dive into the research topics of 'The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies'. Together they form a unique fingerprint.

Cite this